| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65162-811-03 | 65162-811 | HUMAN PRESCRIPTION DRUG | Quinine Sulfate | Quinine | CAPSULE | ORAL | 20160729 | N/A | ANDA | ANDA203729 | Amneal Pharmaceuticals LLC | QUININE SULFATE | 324 mg/1 | 30 CAPSULE in 1 BOTTLE (65162-811-03) |
| 65162-811-09 | 65162-811 | HUMAN PRESCRIPTION DRUG | Quinine Sulfate | Quinine | CAPSULE | ORAL | 20160729 | N/A | ANDA | ANDA203729 | Amneal Pharmaceuticals LLC | QUININE SULFATE | 324 mg/1 | 90 CAPSULE in 1 BOTTLE (65162-811-09) |
| 65162-811-50 | 65162-811 | HUMAN PRESCRIPTION DRUG | Quinine Sulfate | Quinine | CAPSULE | ORAL | 20160729 | N/A | ANDA | ANDA203729 | Amneal Pharmaceuticals LLC | QUININE SULFATE | 324 mg/1 | 500 CAPSULE in 1 BOTTLE (65162-811-50) |